Willis Towers Watson PLC

Willis Towers Watson announced robust Q2 2026 financial results, driven by revenue growth and strategic AI initiatives, with a new target for 30% Adjusted Operating Margin by 2028.

Willis Towers Watson PLC announced the outcomes of its 2026 Annual General Meeting, with shareholders approving all presented proposals, including director elections and auditor ratification.

Willis Towers Watson announced first quarter 2026 financial results, showcasing an 8% revenue increase to $2.4 billion and a 33% rise in diluted EPS to $3.10.

Willis Towers Watson (WTW) announced robust organic revenue growth and significant margin expansion for both the fourth quarter and full year 2025, driven by strategic execution and operational efficiencies.

Willis Towers Watson has completed its acquisition of Newfront Insurance Holdings, Inc., expanding its U.S. middle market presence and accelerating technology-driven strategies.

Willis Towers Watson PLC and its subsidiaries secured a $775 million delayed draw term loan facility to finance a portion of the Newfront Acquisition, refinance existing debt, and support general corporate purposes.

Willis Towers Watson formalizes non-employee director compensation and share ownership guidelines, effective May 20, 2026.

Willis Towers Watson plc announced its first quarter 2026 financial results, showing an 8% increase in reported revenue and a 3% organic revenue growth.

Willis Towers Watson reports a significant return to profitability and strong organic revenue growth for the third quarter and first nine months of 2025, driven by operational efficiencies and the completion of its Transformation program.

Willis Towers Watson PLC announced a significant increase in net income and adjusted earnings per share for the second quarter and first half of 2025, fueled by robust organic revenue growth and reduced transformation costs.

Willis Towers Watson's Q1 2025 revenue decreased by 5% year-over-year due to the sale of TRANZACT, but organic revenue grew by 5% driven by strong performances in both segments.

Willis Towers Watson (WTW) reported a significant net loss for the third quarter of 2024, primarily due to a pre-tax loss on the expected disposal of its TRANZACT business and a related goodwill impairment, while also showing progress in its ongoing transformation program.

Willis Towers Watson PLC reported a significant rebound in net income for 2025, driven by strong organic revenue growth and reduced transformation costs, despite a slight decrease in as-reported revenue due to a prior-year divestiture.

Willis Towers Watson's 2024 results reflect a year of strategic realignment, marked by revenue growth alongside significant restructuring and divestiture impacts.

Willis Towers Watson's 2023 annual report highlights the company's strategic focus on growth, simplification, and transformation, alongside its financial performance and risk factors.

Andrew Jay Krasner, Chief Financial Officer of Willis Towers Watson Plc, reported multiple transactions in common stock on July 15, 2026.

Imran Ahmed Qureshi, Global Head of Geographies of Willis Towers Watson Plc, reported multiple transactions in common stock on July 15, 2026.

Anne Pullum, Co-Head of Corporate Dev. of Willis Towers Watson Plc, reported multiple transactions in common stock on July 15, 2026.

Joseph Stephen Kurpis, PAO and Controller of Willis Towers Watson Plc, reported multiple transactions in common stock on July 15, 2026.

Carl Aaron Hess, Chief Executive Officer and a Director of Willis Towers Watson Plc, reported multiple transactions in common stock on July 15, 2026.

Julie Jarecke Gebauer, Pres.-Health, Wealth & Career of Willis Towers Watson Plc, reported multiple transactions in common stock on July 15, 2026.

Willis Towers Watson PLC announces its 2026 Annual General Meeting to address director elections, auditor appointments, executive compensation, share issuance authority, and an employee share purchase plan.

Willis Towers Watson announces its 2025 Annual General Meeting of Shareholders to be held on May 15, 2025, in Maynooth, Co. Kildare, Ireland.

Willis Towers Watson's 2024 year-end proxy statement details the agenda for the 2025 Annual General Meeting, highlights key governance practices, and provides an overview of executive compensation.

Willis Towers Watson will hold its Annual General Meeting on May 22, 2024, featuring proposals including director elections, auditor ratification, executive compensation approval, and renewal of share issuance authorities.

Willis Towers Watson is holding its Annual General Meeting on May 22, 2024, to vote on key proposals including the election of directors, executive compensation, and the renewal of share issuance authority.

Vanguard Capital Management reports beneficial ownership of 7,106,088 shares, representing 7.54% of Willis Towers Watson's common stock.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Willis Towers Watson PLC following an internal realignment.

Dodge & Cox, an investment adviser, has reported a 7.2% beneficial ownership stake in Willis Towers Watson Public Limited Company.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.6% passive ownership stake in Willis Towers Watson PLC as of March 31, 2025.

Massachusetts Financial Services Company has filed an amended Schedule 13G, reporting a 6.4% beneficial ownership stake in Willis Towers Watson PLC as of December 31, 2024.

First Eagle Investment Management, LLC has filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.4% in Willis Towers Watson PLC as of December 31, 2024.